Cell-based tissue engineering strategies used in the clinical repair of articular cartilage

Brian J. Huang, Jerry C. Hu, Kyriacos A. Athanasiou

Research output: Contribution to journalReview article

101 Citations (Scopus)

Abstract

One of the most important issues facing cartilage tissue engineering is the inability to move technologies into the clinic. Despite the multitude of current research in the field, it is known that 90% of new drugs that advance past animal studies fail clinical trials. The objective of this review is to provide readers with an understanding of the scientific details of tissue engineered cartilage products that have demonstrated a certain level of efficacy in humans, so that newer technologies may be developed upon this foundation. Compared to existing treatments, such as microfracture or autologous chondrocyte implantation, a tissue engineered product can potentially provide more consistent clinical results in forming hyaline repair tissue and in filling the entirety of the defect. The various tissue engineering strategies (e.g., cell expansion, scaffold material, media formulations, biomimetic stimuli, etc.) used in forming these products, as collected from published literature, company websites, and relevant patents, are critically discussed. The authors note that many details about these products remain proprietary, not all information is made public, and that advancements to the products are continuously made. Nevertheless, by understanding the design and production processes of these emerging technologies, one can gain tremendous insight into how to best use them and also how to design the next generation of tissue engineered cartilage products.

Original languageEnglish (US)
Pages (from-to)1-22
Number of pages22
JournalBiomaterials
Volume98
DOIs
StatePublished - Aug 1 2016

Fingerprint

Cartilage
Articular Cartilage
Tissue Engineering
Tissue engineering
Repair
Tissue
Technology
Biomimetics
Stress Fractures
Hyalin
Patents
Scaffolds (biology)
Chondrocytes
Websites
Animals
Clinical Trials
Defects
Research
Pharmaceutical Preparations
Industry

Keywords

  • Autologous chondrocyte implantation
  • Cartilage repair
  • Cartilage tissue engineering
  • Clinical cartilage products
  • Scaffold-free cartilage
  • Scaffolds for cartilage regeneration

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Cell-based tissue engineering strategies used in the clinical repair of articular cartilage. / Huang, Brian J.; Hu, Jerry C.; Athanasiou, Kyriacos A.

In: Biomaterials, Vol. 98, 01.08.2016, p. 1-22.

Research output: Contribution to journalReview article

Huang, Brian J. ; Hu, Jerry C. ; Athanasiou, Kyriacos A. / Cell-based tissue engineering strategies used in the clinical repair of articular cartilage. In: Biomaterials. 2016 ; Vol. 98. pp. 1-22.
@article{ae20bb7faaa348b781785610358d16df,
title = "Cell-based tissue engineering strategies used in the clinical repair of articular cartilage",
abstract = "One of the most important issues facing cartilage tissue engineering is the inability to move technologies into the clinic. Despite the multitude of current research in the field, it is known that 90{\%} of new drugs that advance past animal studies fail clinical trials. The objective of this review is to provide readers with an understanding of the scientific details of tissue engineered cartilage products that have demonstrated a certain level of efficacy in humans, so that newer technologies may be developed upon this foundation. Compared to existing treatments, such as microfracture or autologous chondrocyte implantation, a tissue engineered product can potentially provide more consistent clinical results in forming hyaline repair tissue and in filling the entirety of the defect. The various tissue engineering strategies (e.g., cell expansion, scaffold material, media formulations, biomimetic stimuli, etc.) used in forming these products, as collected from published literature, company websites, and relevant patents, are critically discussed. The authors note that many details about these products remain proprietary, not all information is made public, and that advancements to the products are continuously made. Nevertheless, by understanding the design and production processes of these emerging technologies, one can gain tremendous insight into how to best use them and also how to design the next generation of tissue engineered cartilage products.",
keywords = "Autologous chondrocyte implantation, Cartilage repair, Cartilage tissue engineering, Clinical cartilage products, Scaffold-free cartilage, Scaffolds for cartilage regeneration",
author = "Huang, {Brian J.} and Hu, {Jerry C.} and Athanasiou, {Kyriacos A.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.biomaterials.2016.04.018",
language = "English (US)",
volume = "98",
pages = "1--22",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Cell-based tissue engineering strategies used in the clinical repair of articular cartilage

AU - Huang, Brian J.

AU - Hu, Jerry C.

AU - Athanasiou, Kyriacos A.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - One of the most important issues facing cartilage tissue engineering is the inability to move technologies into the clinic. Despite the multitude of current research in the field, it is known that 90% of new drugs that advance past animal studies fail clinical trials. The objective of this review is to provide readers with an understanding of the scientific details of tissue engineered cartilage products that have demonstrated a certain level of efficacy in humans, so that newer technologies may be developed upon this foundation. Compared to existing treatments, such as microfracture or autologous chondrocyte implantation, a tissue engineered product can potentially provide more consistent clinical results in forming hyaline repair tissue and in filling the entirety of the defect. The various tissue engineering strategies (e.g., cell expansion, scaffold material, media formulations, biomimetic stimuli, etc.) used in forming these products, as collected from published literature, company websites, and relevant patents, are critically discussed. The authors note that many details about these products remain proprietary, not all information is made public, and that advancements to the products are continuously made. Nevertheless, by understanding the design and production processes of these emerging technologies, one can gain tremendous insight into how to best use them and also how to design the next generation of tissue engineered cartilage products.

AB - One of the most important issues facing cartilage tissue engineering is the inability to move technologies into the clinic. Despite the multitude of current research in the field, it is known that 90% of new drugs that advance past animal studies fail clinical trials. The objective of this review is to provide readers with an understanding of the scientific details of tissue engineered cartilage products that have demonstrated a certain level of efficacy in humans, so that newer technologies may be developed upon this foundation. Compared to existing treatments, such as microfracture or autologous chondrocyte implantation, a tissue engineered product can potentially provide more consistent clinical results in forming hyaline repair tissue and in filling the entirety of the defect. The various tissue engineering strategies (e.g., cell expansion, scaffold material, media formulations, biomimetic stimuli, etc.) used in forming these products, as collected from published literature, company websites, and relevant patents, are critically discussed. The authors note that many details about these products remain proprietary, not all information is made public, and that advancements to the products are continuously made. Nevertheless, by understanding the design and production processes of these emerging technologies, one can gain tremendous insight into how to best use them and also how to design the next generation of tissue engineered cartilage products.

KW - Autologous chondrocyte implantation

KW - Cartilage repair

KW - Cartilage tissue engineering

KW - Clinical cartilage products

KW - Scaffold-free cartilage

KW - Scaffolds for cartilage regeneration

UR - http://www.scopus.com/inward/record.url?scp=84966393280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966393280&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2016.04.018

DO - 10.1016/j.biomaterials.2016.04.018

M3 - Review article

VL - 98

SP - 1

EP - 22

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -